Besides, we also performed genomic alteration analysis, prognosis analysis, Gene Set Enrichment Analysis (GSEA), immune cell infiltration analysis, and potential drug sensitivity analysis of PDIA3 in pan-cancer; the most interesting finding is that PDIA3 can predict the immunotherapy response and might be a promising immunotherapy biomarker. Here, PDIA3 is linked to cancer.